资讯

Hepatitis B has the largest global burden of the hepatitis strains. Credit: Orawan Pattarawimonchai/Shutterstock.com. World Hepatitis Day is observed each year on ...
Recognify Life Sciences has reported that its Phase IIb trial of inidascamine to treat CIAS failed to achieve its primary goal.
Roche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.
Filament Health has collaborated with UCL to provide its botanical psilocybin drug candidate, PEX010, for two Phase II research studies.